Understanding the pivotal roles of ACE2 in SARS-CoV-2 infection: from structure/function to therapeutic implication

Abstract In December 2019, a novel respiratory tract infection, from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was detected in China that rapidly spread around the world. This virus possesses spike (S) glycoproteins on the surface of mature virions, like other members of coronavi...

Full description

Bibliographic Details
Main Authors: Amir Pouremamali, Abouzar Babaei, Somayeh Shatizadeh Malekshahi, Ardeshir Abbasi, Nastaran Rafiee
Format: Article
Language:English
Published: SpringerOpen 2022-06-01
Series:Egyptian Journal of Medical Human Genetics
Subjects:
Online Access:https://doi.org/10.1186/s43042-022-00314-9
_version_ 1828195143006552064
author Amir Pouremamali
Abouzar Babaei
Somayeh Shatizadeh Malekshahi
Ardeshir Abbasi
Nastaran Rafiee
author_facet Amir Pouremamali
Abouzar Babaei
Somayeh Shatizadeh Malekshahi
Ardeshir Abbasi
Nastaran Rafiee
author_sort Amir Pouremamali
collection DOAJ
description Abstract In December 2019, a novel respiratory tract infection, from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was detected in China that rapidly spread around the world. This virus possesses spike (S) glycoproteins on the surface of mature virions, like other members of coronaviridae. The S glycoprotein is a crucial viral protein for binding, fusion, and entry into the target cells. Binding the receptor-binding domain (RBD) of S protein to angiotensin-converting enzyme 2 (ACE 2), a cell-surface receptor, mediates virus entry into cells; thus, understanding the basics of ACE2 and S protein, their interactions, and ACE2 targeting could be a potent priority for inhibition of virus infection. This review presents current knowledge of the SARS-CoV-2 basics and entry mechanism, structure and organ distribution of ACE2, and also its function in SARS-CoV-2 entry and pathogenesis. Furthermore, it highlights ACE2 targeting by recombinant ACE2 (rACE2), ACE2 activators, ACE inhibitor, and angiotensin II (Ang II) receptor blocker to control the SARS-CoV-2 infection.
first_indexed 2024-04-12T09:37:26Z
format Article
id doaj.art-105ed658716d4788b44e6931c9a68736
institution Directory Open Access Journal
issn 2090-2441
language English
last_indexed 2024-04-12T09:37:26Z
publishDate 2022-06-01
publisher SpringerOpen
record_format Article
series Egyptian Journal of Medical Human Genetics
spelling doaj.art-105ed658716d4788b44e6931c9a687362022-12-22T03:38:10ZengSpringerOpenEgyptian Journal of Medical Human Genetics2090-24412022-06-0123111010.1186/s43042-022-00314-9Understanding the pivotal roles of ACE2 in SARS-CoV-2 infection: from structure/function to therapeutic implicationAmir Pouremamali0Abouzar Babaei1Somayeh Shatizadeh Malekshahi2Ardeshir Abbasi3Nastaran Rafiee4Department of Virology, Faculty of Medical Sciences, Tarbiat Modares UniversityDepartment of Virology, Faculty of Medical Sciences, Tarbiat Modares UniversityDepartment of Virology, Faculty of Medical Sciences, Tarbiat Modares UniversityDepartment of Immunology, Faculty of Medical Sciences, Tarbiat Modares UniversityDepartment of Virology, Faculty of Medical Sciences, Tarbiat Modares UniversityAbstract In December 2019, a novel respiratory tract infection, from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was detected in China that rapidly spread around the world. This virus possesses spike (S) glycoproteins on the surface of mature virions, like other members of coronaviridae. The S glycoprotein is a crucial viral protein for binding, fusion, and entry into the target cells. Binding the receptor-binding domain (RBD) of S protein to angiotensin-converting enzyme 2 (ACE 2), a cell-surface receptor, mediates virus entry into cells; thus, understanding the basics of ACE2 and S protein, their interactions, and ACE2 targeting could be a potent priority for inhibition of virus infection. This review presents current knowledge of the SARS-CoV-2 basics and entry mechanism, structure and organ distribution of ACE2, and also its function in SARS-CoV-2 entry and pathogenesis. Furthermore, it highlights ACE2 targeting by recombinant ACE2 (rACE2), ACE2 activators, ACE inhibitor, and angiotensin II (Ang II) receptor blocker to control the SARS-CoV-2 infection.https://doi.org/10.1186/s43042-022-00314-9SARS-CoV-2Spike glycoproteinReceptor-binding domainAngiotensin-converting enzyme 2StructureFunction
spellingShingle Amir Pouremamali
Abouzar Babaei
Somayeh Shatizadeh Malekshahi
Ardeshir Abbasi
Nastaran Rafiee
Understanding the pivotal roles of ACE2 in SARS-CoV-2 infection: from structure/function to therapeutic implication
Egyptian Journal of Medical Human Genetics
SARS-CoV-2
Spike glycoprotein
Receptor-binding domain
Angiotensin-converting enzyme 2
Structure
Function
title Understanding the pivotal roles of ACE2 in SARS-CoV-2 infection: from structure/function to therapeutic implication
title_full Understanding the pivotal roles of ACE2 in SARS-CoV-2 infection: from structure/function to therapeutic implication
title_fullStr Understanding the pivotal roles of ACE2 in SARS-CoV-2 infection: from structure/function to therapeutic implication
title_full_unstemmed Understanding the pivotal roles of ACE2 in SARS-CoV-2 infection: from structure/function to therapeutic implication
title_short Understanding the pivotal roles of ACE2 in SARS-CoV-2 infection: from structure/function to therapeutic implication
title_sort understanding the pivotal roles of ace2 in sars cov 2 infection from structure function to therapeutic implication
topic SARS-CoV-2
Spike glycoprotein
Receptor-binding domain
Angiotensin-converting enzyme 2
Structure
Function
url https://doi.org/10.1186/s43042-022-00314-9
work_keys_str_mv AT amirpouremamali understandingthepivotalrolesoface2insarscov2infectionfromstructurefunctiontotherapeuticimplication
AT abouzarbabaei understandingthepivotalrolesoface2insarscov2infectionfromstructurefunctiontotherapeuticimplication
AT somayehshatizadehmalekshahi understandingthepivotalrolesoface2insarscov2infectionfromstructurefunctiontotherapeuticimplication
AT ardeshirabbasi understandingthepivotalrolesoface2insarscov2infectionfromstructurefunctiontotherapeuticimplication
AT nastaranrafiee understandingthepivotalrolesoface2insarscov2infectionfromstructurefunctiontotherapeuticimplication